Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C

Journal of Viral Hepatitis

Volumn 17, Issue 10, 2010, Pages 685-690

  Sutti, S ^a   Vidali, M ^a   Mombello, C ^a   Sartori, M ^b   Albano, E ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

autoimmunity; cytochrome P450; HCV infection; liver fibrosis

Indexed keywords

AUTOANTIBODY; CONFORMATIONAL CYTOCHROME P450 2E1 ANTIBODY; CYTOCHROME P450 2E1; EPITOPE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOPRECIPITATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WESTERN BLOTTING;

ADULT; AGED; AUTOANTIBODIES; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2E1; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77956644838     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01359.x     Document Type: Article

References (27)

1. Strassburg CP, Vogel A, Manns MP. Autoimmunity and hepatitis C. Autoimmun Rev 2003 2: 322 331.
2. Ferri S, Mutarori L, Lenzi M, Granito A, Bianchi FP, Vergani D. HCV and autoimmunity. Curr Pharmac Des 2008 14: 1678 1685.
3. Clifford BD, Donahue D, Smith L et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatol 1995 21: 613 619.
4. Cassani F, Cataleta M, Valentini P et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatol 1997 26: 561 566.
5. Lenzi M, Manotti P, Muratori L et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 1995 36: 749 754.
6. Ferri S, Muratori L, Quarneti C et al. Clinical features and effects of antiviral therapy on anti-liver/kidney microsomal antibodies type 1 positive chronic hepatitis C. J Hepatol 2009 50: 1093 1101.
7. Dalekos GN, Obermayer-Straub P, Bartels M et al. Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol 2003 39: 800 806.
8. Miyakawa H, Kitazawa E, Kikuchi K et al. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity 2001 33: 23 32.
9. Vidali M, Occhino G, Ivaldi A et al. Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C. J Hepatol 2007 46: 605 612.
10. Rigamonti C, Vidali M, Donato MF et al. Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C. Am J Transplant 2009 9: 601 609.
11. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22: 696 699.
12. Gillam EM, Guengerich FP. Maximizing expression of the eukaryotic cytochrome P450 in Escherichia Coli. Methods Enzymol 1996 272: 3 14.
13. Vidali M, Hidestrand E, Eliasson E et al. Use of molecular simulation for mapping conformational CYP2E1 epitopes. J Biol Chem 2004 279: 50949 50955.
14. Ma Y, Thomas MG, Okamoto M et al. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 2002 169: 277 285.
15. Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 2002 22: 339 352.
16. Bogdanos DP, Dalekos GN. Enzymes as target antigens of liver-specific autoimmunity: the case of cytochrome P450s. Curr Med Chem 2008 15: 2285 2292.
17. Vergani D, Mieli-Vergani G. The impact of autoimmunity on hepatocytes. Sem Liver Dis 2007 27: 140 151.
18. Bourdi M, Chen W, Peter RM et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 1996 9: 1159 1166.
19. Hoet P, Graf ML, Bourdi M et al. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluoro carbons. Lancet 1997 350: 556 559.
20. Njoku D, Greenberg RS, Bourdi M et al. Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth Analg 2002 94: 243 249.
21. Vidali M, Stewart SF, Rolla R et al. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatol 2003 37: 277 285.
22. Lu Y, Cederbaum AL. CYP2E1 and oxidative liver injury by alcohol. Free Rad Biol Med 2008 44: 723 738.
23. Eliasson E, Kenna JG. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 1996 50: 573 582.
24. Sutti S, Vidali M, Mombello C et al. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry. J Hepatol 2010 doi:.
25. Ma Y, Bogdanos DP, Hussain MJ et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterol 2006 130: 868 882.
26. Longhi MS, Hussain MJ, Bogdanos DP et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatol 2007 46: 472 484.
27. Robe AJ, Kirby JA, Jones DE, Palmer JM. A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse. Hepatol 2005 41: 1106 1112.